Table 4.
Mortality due to non-communicable diseases by sex and age group in the Taabo HDSS, 2009–2011
| <1 year | 1–4 years | 5–14 years | 15–49 years | 50–64 years | ≥65 years | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|||||||||||||||||||
| Cause of death | aDx | % | aMx (‰) | aDx | % | aMx (‰) | aDx | % | aMx (‰) | aDx | % | aMx (‰) | aDx | % | aMx (‰) | aDx | % | aMx (‰) | |
| Male | |||||||||||||||||||
| Non-communicable diseases* | 8 | 1.1 | 10.8 | 7 | 1.0 | 1.1 | 3 | 0.4 | 0.2 | 17 | 2.4 | 0.7 | 15 | 2.1 | 4.0 | 34 | 4.7 | 21.1 | |
| Acute abdomen | 2 | 0.3 | 2.7 | 3 | 0.4 | 0.4 | 1 | 0.1 | 0.1 | 7 | 1.0 | 0.3 | 5 | 0.8 | 1.4 | 4 | 0.6 | 2.6 | |
| Acute cardiac disease | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Asthma | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Breast neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Chronic obstructive pulmonary disease | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Congenital malformation | 3 | 0.5 | 4.9 | 1 | 0.1 | 0.1 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Diabetes mellitus | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.5 | |
| Digestive neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 3 | 0.4 | 0.1 | 4 | 0.5 | 1.0 | 2 | 0.3 | 1.5 | |
| Epilepsy | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.1 | 2 | 0.2 | 0.1 | 2 | 0.2 | 0.1 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Liver cirrhosis | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Oral neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.3 | 0.1 | 0 | 0.0 | 0.0 | 2 | 0.3 | 1.5 | |
| Other and unspecified cardiac disease | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.3 | 0.5 | 9 | 1.3 | 5.6 | |
| Other and unspecified non- communicable diseases | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.2 | 1 | 0.1 | 0.6 | |
| Other and unspecified neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.2 | 0.0 | 1 | 0.1 | 0.3 | 4 | 0.5 | 2.2 | |
| Renal failure | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.5 | |
| Reproductive neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.3 | 1.1 | |
| Respiratory neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.2 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.4 | |
| Severe anemia | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.1 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.3 | 1.2 | |
| Severe malnutrition | 2 | 0.3 | 3.2 | 2 | 0.3 | 0.3 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.4 | |
| Stroke | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.3 | 0.5 | 5 | 0.6 | 2.9 | |
| Sickle cell with crisis | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Female | |||||||||||||||||||
| Non-communicable diseases* | 1 | 0.2 | 1.7 | 4 | 0.5 | 0.6 | 3 | 0.4 | 0.2 | 14 | 2.0 | 0.6 | 11 | 1.5 | 3.4 | 16 | 2.3 | 10.2 | |
| Acute abdomen | 1 | 0.2 | 1.7 | 3 | 0.4 | 0.4 | 1 | 0.1 | 0.1 | 4 | 0.5 | 0.2 | 2 | 0.3 | 0.8 | 5 | 0.7 | 3.1 | |
| Acute cardiac disease | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.3 | 0 | 0.0 | 0.0 | |
| Asthma | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Breast neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Chronic obstructive pulmonary disease | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Congenital malformation | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Diabetes mellitus | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.2 | 0.1 | 1 | 0.1 | 0.2 | 2 | 0.2 | 1.1 | |
| Digestive neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 | 1 | 0.1 | 0.2 | 3 | 0.4 | 1.7 | |
| Epilepsy | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Liver cirrhosis | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 | 1 | 0.2 | 0.4 | 1 | 0.1 | 0.5 | |
| Oral neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Other and unspecified cardiac disease | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.2 | 0.1 | 1 | 0.2 | 0.4 | 1 | 0.1 | 0.5 | |
| Other and unspecified non- communicable diseases | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.2 | 0.4 | 1 | 0.1 | 0.6 | |
| Other and unspecified neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.3 | 1.2 | |
| Renal failure | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Reproductive neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.2 | 0.5 | 0 | 0.0 | 0.0 | |
| Respiratory neoplasms | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Severe anemia | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.0 | 1 | 0.1 | 0.3 | 0 | 0.0 | 0.0 | |
| Severe malnutrition | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.1 | 2 | 0.3 | 0.1 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.3 | 1.3 | |
| Stroke | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2 | 0.3 | 0.1 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
| Sickle cell with crisis | 0 | 0.0 | 0.0 | 1 | 0.1 | 0.1 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | |
aDx=cause-specific number of deaths in the sex-specific cohort from age a to age x.
% = percentage of all 712 cases of death that could be examined with the InterVA-4 tool.
aMx (‰)=cause-specific mortality rate per 1,000 person-years in the sex-specific cohort from age a to age x.
*
Idiosyncrasies of InterVA-4 lead to minor rounding errors and explain small differences between the disaggregated data and the summed up totals as presented in this study.